Immune regulation in tumor-bearing hosts

Current Opinion in Immunology

Volumn 18, Issue 2, 2006, Pages 214-219

  Baecher Allan, Clare ^a   Anderson, David E ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER VACCINE; INTERLEUKIN 2; TRANSFORMING GROWTH FACTOR BETA;

CANCER IMMUNIZATION; CD4+ CD25+ T LYMPHOCYTE; CELL ACTIVITY; CELL MIGRATION; HUMAN; IMMUNOREGULATION; NONHUMAN; PHENOTYPE; REGULATORY T LYMPHOCYTE; REVIEW; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; TUMOR IMMUNITY;

ANIMALS; CANCER VACCINES; CD4-POSITIVE T-LYMPHOCYTES; HUMANS; NEOPLASMS; T-LYMPHOCYTES, REGULATORY;

EID: 33644660741     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coi.2006.01.010     Document Type: Review

References (41)

1. C. Baecher-Allan, V. Viglietta, and D.A. Hafler Human CD4+CD25+ regulatory T cells Semin Immunol 16 2004 89 98
2. C. Baecher-Allan, J.A. Brown, G.J. Freeman, and D.A. Hafler CD4+CD25high regulatory cells in human peripheral blood J Immunol 167 2001 1245 1253
3. G. Roncador, P.J. Brown, L. Maestre, S. Hue, J.L. Martinez-Torrecuadrada, K.L. Ling, S. Pratap, C. Toms, B.C. Fox, and V. Cerundolo Analysis of FOXP3 protein expression in human CD4+CD25+ regulatory T cells at the single-cell level Eur J Immunol 35 2005 1681 1691
4. K. Wing, P. Larsson, K. Sandstrom, S.B. Lundin, E. Suri-Payer, and A. Rudin CD4+ CD25+ FOXP3+ regulatory T cells from human thymus and cord blood suppress antigen-specific T cell responses Immunology 115 2005 516 525
5. L. Chatenoud, B. Salomon, and J.A. Bluestone Suppressor T cells - they're back and critical for regulation of autoimmunity! Immunol Rev 182 2001 149 163
6. A. Fattorossi, A. Battaglia, G. Ferrandina, A. Buzzonetti, F. Legge, V. Salutari, and G. Scambia Lymphocyte composition of tumor draining lymph nodes from cervical and endometrial cancer patients Gynecol Oncol 92 2004 106 115
7. M. Viguier, F. Lemaitre, O. Verola, M.S. Cho, G. Gorochov, L. Dubertret, H. Bachelez, P. Kourilsky, and L. Ferradini Foxp3 expressing CD4+CD25(high) regulatory T cells are overrepresented in human metastatic melanoma lymph nodes and inhibit the function of infiltrating T cells J Immunol 173 2004 1444 1453
8. int T cells secreted IL-10 but not IFN-γ, characteristic of Tr1s.
9. R. Khattri, T. Cox, S.A. Yasayko, and F. Ramsdell An essential role for Scurfin in CD4+CD25+ T regulatory cells Nat Immunol 4 2003 337 342
10. J.D. Fontenot, M.A. Gavin, and A.Y. Rudensky Foxp3 programs the development and function of CD4+CD25+ regulatory T cells Nat Immunol 4 2003 330 336
11. S. Hori, T. Nomura, and S. Sakaguchi Control of regulatory T cell development by the transcription factor Foxp3 Science 299 2003 1057 1061
12. M.R. Walker, D.J. Kasprowicz, V.H. Gersuk, A. Benard, M. Van Landeghen, J.H. Buckner, and S.F. Ziegler Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25- T cells J Clin Invest 112 2003 1437 1443
13. + Tregs in 104 individuals with ovarian cancer. Their data demonstrated an increased frequency of Tregs that infiltrate tumor tissue, and that increased frequencies of Tregs correlate with stage of disease and are predictive of poor survival. Moreover, CCL22 produced by tumor cells and tumor-associated macrophages was shown to be chemotactic for Tregs.
14. L.A. Ormandy, T. Hillemann, H. Wedemeyer, M.P. Manns, T.F. Greten, and F. Korangy Increased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinoma Cancer Res 65 2005 2457 2464
15. C.P. Gray, P. Arosio, and P. Hersey Association of increased levels of heavy-chain ferritin with increased CD4+ CD25+ regulatory T-cell levels in patients with melanoma Clin Cancer Res 9 2003 2551 2559
16. E. Unitt, S.M. Rushbrook, A. Marshall, S. Davies, P. Gibbs, L.S. Morris, N. Coleman, and G.J. Alexander Compromised lymphocytes infiltrate hepatocellular carcinoma: the role of T-regulatory cells Hepatology 41 2005 722 730
17. K. Noma, Y. Yamaguchi, R. Okita, K. Matsuura, and T. Toge The spleen plays an immunosuppressive role in patients with gastric cancer: involvement of CD62L+ cells and TGF-beta Anticancer Res 25 2005 643 649
18. P.E. Rao, A.L. Petrone, and P.D. Ponath Differentiation and expansion of T cells with regulatory function from human peripheral lymphocytes by stimulation in the presence of TGF-{beta} J Immunol 174 2005 1446 1455
19. M.K. Levings, S. Gregori, E. Tresoldi, S. Cazzaniga, C. Bonini, and M.G. Roncarolo Differentiation of Tr1 cells by immature dendritic cells requires IL-10 but not CD25+CD4+ Tr cells Blood 105 2005 1162 1169
20. U.K. Liyanage, T.T. Moore, H.G. Joo, Y. Tanaka, V. Herrmann, G. Doherty, J.A. Drebin, S.M. Strasberg, T.J. Eberlein, and P.S. Goedegebuure Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma J Immunol 169 2002 2756 2761
21. F. Ichihara, K. Kono, A. Takahashi, H. Kawaida, H. Sugai, and H. Fujii Increased populations of regulatory T cells in peripheral blood and tumor-infiltrating lymphocytes in patients with gastric and esophageal cancers Clin Cancer Res 9 2003 4404 4408
22. M.S. Brady, D.D. Eckels, F. Lee, S.Y. Ree, and J.S. Lee Cytokine production by CD4+ T-cells responding to antigen presentation by melanoma cells Melanoma Res 9 1999 173 180
23. N.G. Chakraborty, L. Li, J.R. Sporn, S.H. Kurtzman, M.T. Ergin, and B. Mukherji Emergence of regulatory CD4+ T cell response to repetitive stimulation with antigen-presenting cells in vitro: implications in designing antigen-presenting cell-based tumor vaccines J Immunol 162 1999 5576 5583
24. T. Sasada, M. Kimura, Y. Yoshida, M. Kanai, and A. Takabayashi CD4+CD25+ regulatory T cells in patients with gastrointestinal malignancies: possible involvement of regulatory T cells in disease progression Cancer 98 2003 1089 1099
25. C. Schaefer, G.G. Kim, A. Albers, K. Hoermann, E.N. Myers, and T.L. Whiteside Characteristics of CD4+CD25+ regulatory T cells in the peripheral circulation of patients with head and neck cancer Br J Cancer 92 2005 913 920
26. A.M. Wolf, D. Wolf, M. Steurer, G. Gastl, E. Gunsilius, and B. Grubeck-Loebenstein Increase of regulatory T cells in the peripheral blood of cancer patients Clin Cancer Res 9 2003 606 612
27. C.S. Hsieh, Y. Liang, A.J. Tyznik, S.G. Self, D. Liggitt, and A.Y. Rudensky Recognition of the peripheral self by naturally arising CD25+ CD4+ T cell receptors Immunity 21 2004 267 277
28. M.S. Jordan, A. Boesteanu, A.J. Reed, A.L. Petrone, A.E. Holenbeck, M.A. Lerman, A. Naji, and A.J. Caton Thymic selection of CD4+CD25+ regulatory T cells induced by an agonist self-peptide Nat Immunol 2 2001 301 306
29. H. Nishikawa, T. Kato, K. Tanida, A. Hiasa, I. Tawara, H. Ikeda, Y. Ikarashi, H. Wakasugi, M. Kronenberg, and T. Nakayama CD4+ CD25+ T cells responding to serologically defined autoantigens suppress antitumor immune responses Proc Natl Acad Sci USA 100 2003 10902 10906
30. H. Nishikawa, T. Kato, I. Tawara, T. Takemitsu, K. Saito, L. Wang, Y. Ikarashi, H. Wakasugi, T. Nakayama, and M. Taniguchi Accelerated chemically induced tumor development mediated by CD4+CD25+ regulatory T cells in wild-type hosts Proc Natl Acad Sci USA 102 2005 9253 9257
31. + Tregs that in a previous study by the authors have been shown to suppress tumor immunity in vivo. Treg suppressive activity declined over time but was regained after renewed tumor antigen-specific stimulation.
32. H.Y. Wang, G. Peng, Z. Guo, E.M. Shevach, and R.F. Wang Recognition of a new ARTC1 peptide ligand uniquely expressed in tumor cells by antigen-specific CD4+ regulatory T cells J Immunol 174 2005 2661 2670
33. H.Y. Wang, D.A. Lee, G. Peng, Z. Guo, Y. Li, Y. Kiniwa, E.M. Shevach, and R.F. Wang Tumor-specific human CD4+ regulatory T cells and their ligands: implications for immunotherapy Immunity 20 2004 107 118 Treg clones were isolated from tumor-infiltrating lymphocytes present in a melanoma specimen and used to screen a tumor-derived cDNA library. The authors identified a peptide recognized by the Tregs that is derived from a cancer testes antigen (LAGE1).
34. P. Yu, Y. Lee, W. Liu, T. Krausz, A. Chong, H. Schreiber, and Y.X. Fu Intratumor depletion of CD4+ cells unmasks tumor immunogenicity leading to the rejection of late-stage tumors J Exp Med 201 2005 779 791
35. T.M. Kuzel DAB(389)IL-2 (denileukin diftitox, ONTAK): review of clinical trials to date Clin Lymphoma 1 Suppl 1 2000 S33 S36
36. F.M. Foss DAB(389)IL-2 (ONTAK): a novel fusion toxin therapy for lymphoma Clin Lymphoma 1 2000 110 116 discussion, 117
37. + Tregs, through the use of a recombinant IL-2 diphtheria toxin conjugate, can enhance vaccine-induced tumor immunity.
38. M.E. Lutsiak, R.T. Semnani, R. De Pascalis, S.V. Kashmiri, J. Schlom, and H. Sabzevari Inhibition of CD4(+)25+ T regulatory cell function implicated in enhanced immune response by low-dose cyclophosphamide Blood 105 2005 2862 2868
39. F. Ghiringhelli, N. Larmonier, E. Schmitt, A. Parcellier, D. Cathelin, C. Garrido, B. Chauffert, E. Solary, B. Bonnotte, and F. Martin CD4+CD25+ regulatory T cells suppress tumor immunity but are sensitive to cyclophosphamide which allows immunotherapy of established tumors to be curative Eur J Immunol 34 2004 336 344
40. M. Beyer, M. Kochanek, K. Darabi, A. Popov, M. Jensen, E. Endl, P.A. Knolle, R.K. Thomas, M. von Bergwelt-Baildon, and S. Debey Reduced frequencies and suppressive function of CD4+CD25hi regulatory T cells in patients with chronic lymphocytic leukemia after therapy with fludarabine Blood 106 2005 2018 2025 This study provides evidence that some pharmacological agents might selectively affect Tregs and be used to inhibit Treg activity in cancer patients. The frequency of Tregs is shown to increase in patients with B cell CLL with increasing stage of disease. Patients receiving the chemotherapeutic agent fludarabine have reduced frequencies of Tregs and Treg activity, in part due to preferential apoptosis of Tregs.
41. G. Peng, Z. Guo, Y. Kiniwa, K.S. Voo, W. Peng, T. Fu, D.Y. Wang, Y. Li, H.Y. Wang, and R.F. Wang Toll-like receptor 8-mediated reversal of CD4+ regulatory T cell function Science 309 2005 1380 1384